ArticleEClinicalMedicine2025

Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus dolutegravir as a two-drug regimen in adults naive to antiretroviral therapy (DYNAMIC): 24-week results from a randomised phase 2b study.

Samit R Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.